Auph short interest.

The European Commission has approved Aurinia Pharmaceuticals' ( NASDAQ: AUPH) Lupkynis (voclosporin) for lupus nephritis. The approval triggers a $30M milestone payment from partner Otsuka ...Short interest is the volume of POINT Biopharma Global shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 4,390,000 shares of PNT short. 5.09% of POINT Biopharma Global's shares are currently sold short. Learn More on POINT Biopharma Global's current short interest.As of November 15th, there was short interest totaling 30,500 shares, a decrease of 27.2% from the October 31st total of 41,900 shares. Based on an average daily volume of 37,400 shares, the short-interest ratio is presently 0.8 days. Currently, 1.0% of the company's shares are sold short. ... (AUPH), Arch Therapeutics ...Web

The u/AnalystRipper community on Reddit. Reddit gives you the best of the internet in one place.Aug 24, 2022 · Approximately 10% of the overall float is currently held short. Two directors bought a collective 10,000 shares in early March. Prior to that several insiders sold just over $1.2 million worth of ... AUPH 4.86%. Apple Inc. $191.24. AAPL 0.68%. Sarepta Therapeutics Inc. ... Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance ...

“The possibility of a short squeeze is one reason some analysts look at a high amount of short interest as a bullish indicator. Short Interest is the fuel, performance is the fuse, says ShortSqueeze.com” - USA Today ...short sellers, not financial results, are driving up …

Nov 29, 2023 · Short Interest. Percentage of Shares Shorted 11.97% of the outstanding shares of Aurinia Pharmaceuticals have been sold short. Short Interest Ratio / Days to Cover Aurinia Pharmaceuticals has a short interest ratio ("days to cover") of 9.2. Change versus previous month The short interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is 17.19 million shares and it means that shorts have 11.64 day(s) to cover. The consensus price target of analysts on Wall Street is $13.21, which implies an increase of 34.6% to the stock’s current value.Despite upbeat remarks from its chief executive ahead of the earnings, Aurinia’s (NASDAQ:AUPH) 2022 sales guidance fell short of expectations as net revenue for the year dropped ~9% YoY to $45 ...Short Interest. Percentage of Shares Shorted 11.97% of the outstanding shares of Aurinia Pharmaceuticals have been sold short. Short Interest Ratio / Days to …Are you a smaller woman looking for a new hairstyle? Short haircuts can be a great way to make a bold statement and show off your features. But with so many options available, it can be hard to know which one is right for you.

Some thoughts on AUPH: 1. As cited, AUPH reported Lupkynis sales +46% YOY, +20% over Q1, and raised full year guidance to $150 million - $160 million, but admittedly is only scratching the surface ...

Jul 15, 2022 · Biogen has more recently been seen as a potential acquirer of AUPH after a Stat News report said that Biogen is working with Goldman Sachs to find potential targets for the company. Aurinia ( AUPH ...

Sep 30, 2023 · Net amortization of premiums and discounts on short-term investments (8,836) (14) Share-based compensation expense: 33,543 25,398 Write-down of inventory: 916 2,464 Other, net (3,910) 601 Net changes in operating assets and liabilities: Accounts receivable, net (24,463) (26,356) Inventories, net (8,984) (8,458) Prepaid expenses and other ... Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Short interest for Aurinia Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Aurinia Pharmaceuticals's stock. Short interest data is...On another thread there us a guy who is misguided and blaming mgmt. Claims short interest is going up. I checked itsv8.5% as of May 15th. We should soon find out if short interest has gone up. Reply ... Nasdaq AUPH Short interest. Reply More posts from r/AUPH. subscribers .Aurinia Pharmaceuticals (AUPH) closed the last trading session at $9.80, gaining 0.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...AUPH / Aurinia Pharmaceuticals Inc short borrow fee rates are shown in the following table. This table shows the interest rate that must be paid by a short seller of US:AUPH to the lender of that security. This fee is shown as an annual percentage rate (APR).

A short bio should include an introduction, information about education, relevant information regarding awards and achievements, and a conclusion. Depending on the purpose of the bio, it may also include relevant work experience and qualifi...Zhanna Hapanovich/iStock via Getty Images. Aurinia Pharmaceuticals (NASDAQ: AUPH) may be worth $45-$53/share in a possible sale and may see interest from other pharma cos. besides Bristol Myers ...Short Interest. Most Shorted. Largest Increase. Largest Decrease. Calculators. Margin Calculator. ... Aurinia Pharmaceuticals (AUPH) is scheduled to report earnings on February 27, 2024.Institutional Owners: 318 total, 304 long only, 0 short only, 14 long/short - change of 1.92% MRQ Average Portfolio Allocation: 0.0605 % - change of -12.95% MRQShort interest is the volume of POINT Biopharma Global shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 4,390,000 shares of PNT short. 5.09% of POINT Biopharma Global's shares are currently sold short. Learn More on POINT Biopharma Global's current short interest.Sep 21, 2023 · Aurinia Pharmaceuticals ( NASDAQ: AUPH) named Dr. Robert Foster as a new board member Thursday as part of an agreement with its major shareholder and investment management firm, MKT Capital Ltd ...

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -25.98M. -347.29%. Get the latest Ardelyx Inc (ARDX) real-time quote, historical ...WebDec 1, 2023 · The company has $337.90 million in cash and $93.21 million in debt, giving a net cash position of $244.69 million or $1.70 per share. Cash & Cash Equivalents.

Aurinia Pharmaceuticals ( NASDAQ: AUPH) rose 5% amid speculation the company may be a takeover target after Tuesday's patent settlement with Sun Pharmaceuticals. Aurinia ( AUPH) surged 38% on ...Cash received for interest $ ... (Nasdaq) under the symbol AUPH. 2. Summary of Significant Accounting Policies . Basis of Presentation. ... September 2022, the fixed lease term ended on the Victoria lease and the Company exercised its right to enter into a short-term month to month lease, of which expenses are incurred in SG&A. ...For fiscal 2023, the company expects LUPKYNIS revenue to be between $120 million and $140 million, representing annual growth of 15.4% to 34.6% in terms of net product sales. While analysts expect ...Sep 21, 2023 · Aurinia Pharmaceuticals ( NASDAQ: AUPH) named Dr. Robert Foster as a new board member Thursday as part of an agreement with its major shareholder and investment management firm, MKT Capital Ltd ... As women age, their hair can start to thin and become more difficult to manage. Many women over 50 opt for shorter haircuts that are easier to style and maintain. Short haircuts are also a great way to look stylish and modern while still em...As women age, their hair can start to thin and become more difficult to manage. Many women over 50 opt for shorter haircuts that are easier to style and maintain. Short haircuts are also a great way to look stylish and modern while still em...

22 votes, 16 comments. 1K subscribers in the AUPH community. A place to discuss Aurinia Pharmaceuticals, Inc.

Overview of financial data and news for Aurinia Pharmaceuticals Inc., Nasdaq:AUPH

Financials. AUPH has a market cap of $1.3bn and a cash balance of $389mn. Research and development expenses were USD 9.9 million for 4Q. Selling, general and administrative expenses, inclusive of ...The short interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is 17.19 million shares and it means that shorts have 11.64 day(s) to cover. The consensus price target of analysts on Wall Street is $13.21, which implies an …Oct 29, 2021 · Zhanna Hapanovich/iStock via Getty Images. Aurinia Pharmaceuticals (NASDAQ: AUPH) may be worth $45-$53/share in a possible sale and may see interest from other pharma cos. besides Bristol Myers ... NP. VQNPX - Vanguard Growth and Income Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value. 28,200. -40.63.Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) was the recipient of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 8,290,000 shares, a decline of 27.7% from the October 31st total of 11,460,000 shares.WebLive Short Interest data, Utilization, Cost to borrow and much more for Aurinia Pharmaceuticals Inc., Nasdaq:AUPHAurinia Pharmaceuticals last released its quarterly earnings results on November 2nd, 2023. The biotechnology company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.17) by $0.08. The business earned $54.52 million during the quarter, compared to the consensus estimate of $38.41 million.Short interest is the volume of Aurinia Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders …AUPH | Aurinia Pharmaceuticals by Finance Ai provides AUPH | Aurinia Pharmaceuticals short interest and earnings date annual report with insider trading history and institutional ownership breakdown.

AUPH. Buyout / ShortSquueze. This jumped from $22 to $28 at 3:54 pm Friday on rumor of BMY buying them out. No news over the weekend . The short interest is 17 percent. Thinking even without a confirmed buyout, shorts may be stuck. Good luck if you trade it.Jan 5, 2023 · AUPH has multiple downside risks that investors need to consider when managing their position. First, Aurinia is still recording losses and reported a net loss of $82.1M for the first three ... The average one-year price target for AUPH / Aurinia Pharmaceuticals Inc is $14.28. The forecasts range from a low of $12.12 to a high of $15.75. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond ... Spot open interest trends for Aurinia Pharmaceuticals - Common Shares (AUPH) and look for trend reversals. Evaluating open interest along with stock price data is useful to traders looking to confirm bullish or bearish sentiment. ... [Short ATM, Long OTM] Call Butterflies [Long ATM, Short OTM] Put Butterflies [Short ATM, Long OTM] Put ...Instagram:https://instagram. micro e mini futures brokersbest metatrader 5 brokersiphone 15 clonestock price of airbnb Aurinia Pharma press release (NASDAQ:AUPH): Q3 GAAP EPS of -$0.09 beats by $0.08.; Revenue of $54.52M (-2.3% Y/Y) beats by $16.02M. Achieved European pricing and reimbursement milestone triggering ...Oct 29, 2021 · Zhanna Hapanovich/iStock via Getty Images. Aurinia Pharmaceuticals (NASDAQ: AUPH) may be worth $45-$53/share in a possible sale and may see interest from other pharma cos. besides Bristol Myers ... the sphere las vegas capacityday trading on schwab Short Interest. Prev. Close. Compare to Peers. More on AUPH. Trending Analysis. Trending News. Seeking Alpha - Power to Investors. Power to Investors. Follow us. Download app. Subscription Support ... whiskeyvest review 316 K. 119 K. +166%. Loading... Stock Performance by Trading Session. Trading Session Volume Relative to Daily Average. View statistical stock analysis for Aurinia Pharmaceuticals - Common Shares (AUPH). Choose from a list of different historical perspectives such as intraday stock behavior, gap up moves, gap down moves, large …Web2023-03-10 Short sale volume (not short interest) for $AUPH is 38%. http://shortvolumes.com/?t=AUPH $AEZS 37% $REGN 56% $XLV 46%. 11 Mar 2023 12:54:01WebAuph only had 1 month of sales last quarter, due to insurance companys taking 20 to 50 days to approve each patient...thats the reason for sales short fall Reply Like (7) d